IP Library Granted Patent US 9,746,464
Granted Patent B2
US 9,746,464 · App. 14/887,238 · Granted Aug 29, 2017

High sensitivity quantitation of peptides by mass spectrometry

Inventor: Norman Leigh Anderson (Washington, DC)
Assignee: ANDERSON FORSCHUNG GROUP, LLC.
G01N33/54306G01N33/6848C12Q1/28G01N33/491G01N33/6803G01N2458/15G01N2560/00Y10T436/10Y10T436/107497Y10T436/25Y10T436/25125
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,746,464
App. No.
14/887,238
Granted
Aug 29, 2017
Kind
B2
Abstract

The instant invention provides an economical flow-through method for determining amount of target proteins in a sample. An antibody preparation (whether polyclonal or monoclonal, or any equivalent specific binding agent) is used to capture and thus enrich a specific monitor peptide (a specific peptide fragment of a protein to be quantitated in a proteolytic digest of a complex protein sample) and an internal standard peptide (the same chemical structure but including stable isotope labels). Upon elution into a suitable mass spectrometer, the natural (sample derived) and internal standard (isotope labeled) peptides are quantitated, and their measured abundance ratio used to calculate the abundance of the monitor peptide, and its parent protein, in the initial sample.

Claims (13)

1. A method for quantifying the amount of an unlabeled analyte in a biological sample, comprising:

measuring the amount of the unlabeled analyte and two or more stable-isotopically labeled versions of said analyte in said biological sample by mass spectrometry,

wherein said two or more stable-isotopically labeled versions of said unlabeled analyte are present at different known concentration levels from each other and have isotopic masses that differ from each other and from the mass of the unlabeled analyte in a manner that can be distinguished by a mass spectrometer, either through direct measurement of molecular mass or through mass measurement of fragments,

wherein measurement of the known amount of said two or more stable-isotopically labeled versions of the analyte provides an internal standard curve and

wherein the amount of said unlabeled analyte in said sample is calculated by comparison to said standard curve.

2. The method of claim 1 , wherein three or more stable-isotopically labeled versions of said unlabeled analyte are present at different known concentration levels from each other and said labeled versions have isotopic masses that differ from each other and from the mass of the unlabeled analyte, and

wherein measurement of the known amount of said three or more stable-isotopically labeled versions of the analyte provides said internal standard curve.

3. The method of claim 2 , wherein three stable-isotopically labeled versions of said unlabeled analyte are present.

4. The method of claim 1 , wherein said analyte is a peptide.

5. The method of claim 4 , wherein said peptide is a fragment of a protein.

6. The method of claim 1 , wherein the concentration levels of said at least two or more stable-isotopically labeled versions of said analyte cover a ten-fold range of concentration.

7. The method of claim 1 , wherein said biological sample is a bodily fluid.

8. The method of claim 1 , wherein said biological sample is a proteolytic digest of a bodily fluid.

Continuity (8)
Continuation 13944736 · Jul 17, 2013
Continuation 12628928 · Dec 1, 2009
Division 10676005 · Oct 2, 2003
Provisional Application 60496037 · Aug 18, 2003
Provisional Application 60449190 · Feb 20, 2003
Provisional Application 60420613 · Oct 23, 2002
Provisional Application 60415499 · Oct 3, 2002
Related Publication 20160146796A1 · May 26, 2016